The encyclopedia · Advertising & PR · Marketing decision · 2026
Garnier's 'clinically proven' serum ad banned — the study didn't match the claim
Garnier's ad said its serum was 'clinically proven to reduce hyperpigmentation in 2 weeks'. The ASA banned it: the study didn't fit the claim.
L'Oréal · Garnier · 2026-04
What happened
On 28 October 2025 a video-on-demand ad for Garnier's new Vitamin Cg Serum said: 'Dark spots? Take one brighter step with new Garnier Vitamin Cg Serum. Now with a 4% active concentration, clinically proven to reduce hyperpigmentation in 2 weeks. 99% agree skin is glowing.' The small print read '** 72% of 111 women agree. Clinical study, 44 subjects 10 weeks'.
L'Oréal admitted the on-screen qualifier was an error — it should have read only 'Clinical study, 44 subjects, 10 weeks' — and said the formulation contained niacinamide, ascorbyl glucoside and Melasyl with known anti-pigmentation effects. It provided a clinical study and a published paper on Melasyl to substantiate the claim.
On 22 April 2026 the ASA upheld the complaint. The trial had a small sample with no evidence it was clinically robust and its randomisation method was not adequately documented. The self-reported agreement was subjective and could not support a 'clinically proven' claim, and the Melasyl paper assessed prevention of pigmentation in healthy skin, not treatment of established hyperpigmentation. The ad breached CAP rules 3.1, 3.7 and 12.1 and must not appear again.
Why it happened
- 'Clinically proven' is a heavyweight claim — 44 subjects without documented randomisation cannot carry it.
- The study ran in a hotter, sunnier climate on different skin types — conditions the UK ad's outdoor scenes never mentioned.
- The qualifier was an admitted error that mixed the 72% subjective agreement with the 44-subject study.
- The Melasyl paper studied preventing pigment in healthy skin — the ad claimed treatment of spots that already exist.
The lesson
A clinical claim needs a matching trial: Garnier's 'clinically proven in 2 weeks' rested on 44 subjects in a hotter climate with no documented randomisation — the ASA banned the ad.
Aftermath
The ASA ruled the ad must not appear again and told L'Oréal not to state or imply the product was clinically proven to reduce hyperpigmentation in two weeks unless it held robust evidence.
Sources
spotted an error? The club wants to know.
More like this
Victoria's Secret went quiet when its new China ambassador fell into a copyright row
Plucharm's 'Nobel-winning' hair tonic ads faked proof and a sell-out
Freis Labo's 'after NHK, sold out' serum ads buried a fake campaign
Somewhere, someone solved the problem this company failed at. 2nd Opinion →
Comments · 0
Sign in to join the comments.